Key Financial Data Of Reporting Company

Carna Biosciences, Inc. - Filing #7722864

Concept 2018-01-01 to
2018-06-30
As at
2018-06-30
2018-04-01 to
2018-06-30
2017-01-01 to
2017-12-31
As at
2017-12-31
As at
2017-06-30
2017-04-01 to
2017-06-30
2017-01-01 to
2017-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
399,114,000 JPY
657,516,000 JPY
326,799,000 JPY
Ordinary profit (loss)
-443,148,000 JPY
-711,496,000 JPY
-297,318,000 JPY
Net assets
984,310,000 JPY
1,377,908,000 JPY
1,491,215,000 JPY
Total assets
1,959,039,000 JPY
2,190,386,000 JPY
2,193,269,000 JPY
Basic earnings (loss) per share
-51.17
-30.79
-78.53
-21.21
-34.03
Diluted earnings per share
Equity-to-asset ratio
0.495 xbrli:pure
0.622 xbrli:pure
0.678 xbrli:pure
Net cash provided by (used in) operating activities
-495,190,000 JPY
-561,055,000 JPY
-222,568,000 JPY
Net cash provided by (used in) investing activities
-49,759,000 JPY
-38,131,000 JPY
-28,738,000 JPY
Net cash provided by (used in) financing activities
210,337,000 JPY
295,814,000 JPY
-15,582,000 JPY
Cash and cash equivalents
1,519,562,000 JPY
1,856,218,000 JPY
1,892,419,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.